Scholarly Index
Frank L. van de Veerdonk
Radboud University Nijmegen; 41,220 total citations; 342 total publications; best world rank #48
Radboud University Nijmegen
41,220Total citations
342Total publications
97H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| COVID-19 Clinical Research Studies | Lifetime | 83 | NL 3 | 99.44 |
| Long-Term Effects of COVID-19 | Lifetime | 62 | NL 1 | 99.12 |
| Antifungal resistance and susceptibility | Lifetime | 59 | NL 6 | 99.62 |
| Inflammasome and immune disorders | Lifetime | 48 | NL 4 | 99.27 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 103 | NL 5 | 99.37 |
| Fungal Infections and Studies | Lifetime | 94 | NL 7 | 99.29 |
| Infectious Diseases and Mycology | Lifetime | 160 | NL 9 | 97.53 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 514 | NL 25 | 96.22 |
| Immune responses and vaccinations | Lifetime | 182 | NL 14 | 94.27 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | Lifetime | 600 | NL 18 | 95.26 |
| Long-Term Effects of COVID-19 | 2021-2025 | 55 | NL 1 | 99.11 |
| COVID-19 Clinical Research Studies | 2021-2025 | 123 | NL 2 | 99.31 |
| Antifungal resistance and susceptibility | 2021-2025 | 97 | NL 5 | 97.76 |
| Fungal Infections and Studies | 2021-2025 | 100 | NL 7 | 96.98 |
| Immunodeficiency and Autoimmune Disorders | 2021-2025 | 166 | NL 8 | 95.67 |
| Immune responses and vaccinations | 2021-2025 | 144 | NL 27 | 84.75 |
| Infectious Diseases and Mycology | 2021-2025 | 510 | NL 17 | 68.73 |